Wagstaff J - Search Results

1

IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer.

Ogilvie AC, Hack CE, Wagstaff J, van Mierlo GJ, Erenberg AJ, Thomsen LL, Hoekman K, Rankin EM. Ogilvie AC, et al. Among authors: wagstaff j. J Immunol. 1996 Jan 1;156(1):389-94. J Immunol. 1996. PMID: 8598489 Clinical Trial.

2

Activation of the complement system during immunotherapy with recombinant IL-2. Relation to the development of side effects.

Thijs LG, Hack CE, Strack van Schijndel RJ, Nuijens JH, Wolbink GJ, Eerenberg-Belmer AJ, Van der Vall H, Wagstaff J. Thijs LG, et al. Among authors: wagstaff j. J Immunol. 1990 Mar 15;144(6):2419-24. J Immunol. 1990. PMID: 2313099

3

Renal cell carcinoma and interleukin-2: a review.

Wagstaff J, Baars JW, Wolbink GJ, Hoekman K, Eerenberg-Belmer AJ, Hack CE. Wagstaff J, et al. Eur J Cancer. 1995;31A(3):401-8. doi: 10.1016/0959-8049(94)00494-p. Eur J Cancer. 1995. PMID: 7540404 Review. No abstract available.

4

Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.

Dercksen MW, Hoekman K, ten Bokkel Huinink WW, Rankin EM, Dubbelman R, van Tinteren H, Wagstaff J, Pinedo HM. Dercksen MW, et al. Among authors: wagstaff j. Br J Cancer. 1993 Nov;68(5):996-1003. doi: 10.1038/bjc.1993.468. Br J Cancer. 1993. PMID: 7692922 Free PMC article.

5

The release of interleukin-8 during intravenous bolus treatment with interleukin-2.

Baars JW, Wolbink GJ, Hart MH, Hack CE, Eerenberg-Belmer AJ, Pinedo HM, Wagstaff J. Baars JW, et al. Among authors: wagstaff j. Ann Oncol. 1994 Dec;5(10):929-34. doi: 10.1093/oxfordjournals.annonc.a058732. Ann Oncol. 1994. PMID: 7696165 Free article. Clinical Trial.

6

Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy.

Hack CE, Ogilvie AC, Eisele B, Jansen PM, Wagstaff J, Thijs LG. Hack CE, et al. Among authors: wagstaff j. Prog Clin Biol Res. 1994;388:335-57. Prog Clin Biol Res. 1994. PMID: 7831367 Review.

7

C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.

Hack CE, Ogilvie AC, Eisele B, Eerenberg AJ, Wagstaff J, Thijs LG. Hack CE, et al. Among authors: wagstaff j. Intensive Care Med. 1993;19 Suppl 1:S19-28. doi: 10.1007/BF01738946. Intensive Care Med. 1993. PMID: 8053997 Review.

8

A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2.

Ogilvie AC, Baars JW, Eerenberg AJ, Hack CE, Pinedo HM, Thijs LG, Wagstaff J. Ogilvie AC, et al. Among authors: wagstaff j. Br J Cancer. 1994 Mar;69(3):596-8. doi: 10.1038/bjc.1994.109. Br J Cancer. 1994. PMID: 8123494 Free PMC article.

9

Therapy with interleukin-2 induces the systemic release of phospholipase-A2.

Wolbink GJ, Schalkwijk C, Baars JW, Wagstaff J, van den Bosch H, Hack CE. Wolbink GJ, et al. Among authors: wagstaff j. Cancer Immunol Immunother. 1995 Nov;41(5):287-92. doi: 10.1007/BF01517216. Cancer Immunol Immunother. 1995. PMID: 8536274 Free PMC article. Clinical Trial.

10

Angioneurotic oedema and urticaria during therapy with interleukin-2 (IL-2).

Baars JW, Wagstaff J, Hack CE, Wolbink GJ, Eerenberg-Belmer AJ, Pinedo HM. Baars JW, et al. Among authors: wagstaff j. Ann Oncol. 1992 Mar;3(3):243-4. doi: 10.1093/oxfordjournals.annonc.a058162. Ann Oncol. 1992. PMID: 1586626 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters